Dolphin Medical Services open offer at ₹4.80 per share
Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar have launched a mandatory open offer to acquire 39,25,988 equity shares, representing 26.00% of the voting capital of Dolphin Medical Services Limited, at ₹4.80 per share from July 09, 2026, to July 22, 2026. The offer follows a Share Purchase Agreement to acquire control, with a total consideration of ₹1,88,44,743 assuming full acceptance, and is managed by Rarever Financial Advisors Private Limited.

*this image is generated using AI for illustrative purposes only.
Mr. Amarandhar Reddy Kotha and Mr. Mallour Rajesh Kumar have initiated a mandatory open offer to acquire 39,25,988 equity shares, representing 26.00% of the voting capital of Dolphin Medical Services Limited, at a price of ₹4.80 per share. The offer, scheduled from July 09, 2026, to July 22, 2026, follows a Share Purchase Agreement (SPA) dated May 15, 2026, for the acquisition of control. The acquirers have agreed to purchase 31,63,390 shares representing 20.95% of the voting share capital from the existing promoters, Mr. Gude Venkata Mohan Prasad and Mrs. Lakshmi Sudha Madala, at a negotiated price of ₹1.80 per share.
The open offer is being made in compliance with Regulation 4 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Rarever Financial Advisors Private Limited has been appointed as the Manager to the Offer, while Integrated Registry Management Services Private Limited is the Registrar to the Offer. The acquirers have opened an escrow account with Axis Bank Limited and deposited ₹47,20,000, which is more than 25% of the total consideration payable under the offer, assuming full acceptance.
The offer price of ₹4.80 per share has been determined in accordance with Regulation 8(2) of the SEBI (SAST) Regulations, 2011, being the highest of the volume-weighted average market price for the 60 trading days preceding the public announcement. The maximum consideration payable by the acquirers, assuming full acceptance, aggregates to ₹1,88,44,743. The acquirers have certified that they have adequate financial resources to meet the obligations of the offer, funded through their own net worth without borrowings.
Offer Details
| Parameter | Details |
|---|---|
| Target Company | Dolphin Medical Services Limited |
| Acquirer 1 | Mr. Amarandhar Reddy Kotha |
| Acquirer 2 | Mr. Mallour Rajesh Kumar |
| Offer Size | 39,25,988 Equity Shares (26.00% of Voting Capital) |
| Offer Price | ₹4.80 per Equity Share |
| Total Consideration | ₹1,88,44,743 (assuming full acceptance) |
| Offer Opening Date | July 09, 2026 |
| Offer Closing Date | July 22, 2026 |
| Manager to the Offer | Rarever Financial Advisors Private Limited |
| Registrar to the Offer | Integrated Registry Management Services Private Limited |
| Designated Stock Exchange | BSE Limited |
Background of the Offer
The offer is triggered by the acquisition of 31,63,390 shares from the promoter sellers, which will result in the acquirers obtaining control over the target company. Upon completion of the underlying transaction and the open offer, the acquirers will hold 70,89,378 equity shares, representing 46.95% of the voting share capital. The acquirers intend to continue the existing business operations of Dolphin Medical Services Limited, which is engaged in providing diagnostic and healthcare services.
The equity shares of the target company are listed on BSE with the symbol ‘DOLPHMED’. The trading in these shares is currently restricted to every Monday due to suspension for non-payment of ALF dues, though the company has filed for revocation. The offer is not subject to any minimum level of acceptance from public shareholders.
What strategic changes or operational improvements do the new acquirers plan to implement to enhance the value of Dolphin Medical Services?
How will the company's application for the revocation of trading suspension impact the liquidity and valuation of the stock following the open offer?
Given the significant price difference between the negotiated promoter deal and the open offer, what is the expected level of acceptance from public shareholders?





























